Norland Biotech
Norland Biotech, a leading name in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2002, the company has established itself as a pioneer in the development of innovative biopharmaceuticals and diagnostic solutions. Norland Biotech's core offerings include advanced monoclonal antibodies and cutting-edge diagnostic kits, distinguished by their high specificity and reliability. The company has achieved significant milestones, including numerous patents and collaborations with major research institutions, solidifying its position in the competitive biotech landscape. With a commitment to quality and innovation, Norland Biotech continues to enhance its market presence, contributing to advancements in healthcare and life sciences.
DitchCarbon Score
How does Norland Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Norland Biotech's score of 0 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Norland Biotech's reported carbon emissions
Norland Biotech, headquartered in CN, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting its emissions. As the industry increasingly prioritises sustainability, it is essential for Norland Biotech to establish clear targets and strategies to address carbon emissions and contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Norland Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
